Pedro Diaz

Supervisor at BioReliance - Rockville, Maryland, US

Pedro Diaz's Contact Details
HQ
(301) 738-1000
Location
Company
BioReliance
Pedro Diaz's Company Details
BioReliance logo, BioReliance contact details

BioReliance

Rockville, Maryland, US • 1000 - 4999 Employees
BioTech/Drugs

This channel is intended only for US and Canadian visitors. The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada. An unaffiliated and unrelated company, Merck & Co. holds the rights in the trademark MERCK in the US and Canada. Bringing pharma and biopharma healthcare solutions to life is complex, requiring specialist knowledge and expertise at every step. This is why MilliporeSigma offers the BioReliance® portfolio – an offering of exceptional, risk-mitigating approaches, testing, critical services and customized, complete solutions to help you bring life-changing drugs to market, faster. We are a leading GMP and GLP testing services provider for the development of your therapeutics. Regulatory bodies such as the US Food & Drug Administrators (FDA) and the Medicines and Healthcare products Regulatory Agency (MHRA) require products to be tested for compliance before release. With locations worldwide, we offers more than 1,000 tests and complementary services related to biologics safety testing and product characterization. For more information, visit www.sigmaaldrich.com/biosafetytesting

Pharmaceutical Testing Pharmaceutical Product Development
Details about BioReliance
Frequently Asked Questions about Pedro Diaz
Pedro Diaz currently works for BioReliance.
Pedro Diaz's role at BioReliance is Supervisor.
Pedro Diaz's email address is ***@bioreliance.com. To view Pedro Diaz's full email address, please signup to ConnectPlex.
Pedro Diaz works in the BioTech/Drugs industry.
Pedro Diaz's colleagues at BioReliance are Beatrice Thompson, Irene Griff, Katherine Murphy, Jackie King, Jessy Makeyeva, Kathy Vincent, Melissa Cutliff and others.
Pedro Diaz's phone number is (301) 738-1000
See more information about Pedro Diaz